302 related articles for article (PubMed ID: 31633497)
1. Papillary thyroid microcarcinoma: optimal management versus overtreatment.
Walgama E; Sacks WL; Ho AS
Curr Opin Oncol; 2020 Jan; 32(1):1-6. PubMed ID: 31633497
[TBL] [Abstract][Full Text] [Related]
2. Low-risk papillary thyroid microcarcinoma: Optimal management toward a more conservative approach.
Ramundo V; Sponziello M; Falcone R; Verrienti A; Filetti S; Durante C; Grani G
J Surg Oncol; 2020 May; 121(6):958-963. PubMed ID: 32189352
[TBL] [Abstract][Full Text] [Related]
3. A Clinical Framework to Facilitate Risk Stratification When Considering an Active Surveillance Alternative to Immediate Biopsy and Surgery in Papillary Microcarcinoma.
Brito JP; Ito Y; Miyauchi A; Tuttle RM
Thyroid; 2016 Jan; 26(1):144-9. PubMed ID: 26414743
[TBL] [Abstract][Full Text] [Related]
4. Conservative Surveillance Management of Low-Risk Papillary Thyroid Microcarcinoma.
Miyauchi A; Ito Y
Endocrinol Metab Clin North Am; 2019 Mar; 48(1):215-226. PubMed ID: 30717903
[TBL] [Abstract][Full Text] [Related]
5. Active Surveillance in Papillary Thyroid Microcarcinomas is Feasible and Safe: Experience at a Single Italian Center.
Molinaro E; Campopiano MC; Pieruzzi L; Matrone A; Agate L; Bottici V; Viola D; Cappagli V; Valerio L; Giani C; Puleo L; Lorusso L; Piaggi P; Torregrossa L; Basolo F; Vitti P; Tuttle RM; Elisei R
J Clin Endocrinol Metab; 2020 Mar; 105(3):e172-80. PubMed ID: 31652318
[TBL] [Abstract][Full Text] [Related]
6. Active Surveillance as First-Line Management of Papillary Microcarcinoma.
Ito Y; Miyauchi A
Annu Rev Med; 2019 Jan; 70():369-379. PubMed ID: 30230964
[TBL] [Abstract][Full Text] [Related]
7. Active surveillance of low-risk papillary thyroid microcarcinomas in Japan and other countries: a review.
Ito Y; Miyauchi A
Expert Rev Endocrinol Metab; 2020 Jan; 15(1):5-12. PubMed ID: 31902250
[No Abstract] [Full Text] [Related]
8. Active Surveillance as an Effective Management Option for Low-Risk Papillary Thyroid Microcarcinoma.
Jeon MJ; Kim WG; Kim TY; Shong YK; Kim WB
Endocrinol Metab (Seoul); 2021 Aug; 36(4):717-724. PubMed ID: 34379969
[TBL] [Abstract][Full Text] [Related]
9. Surgery alone for papillary thyroid microcarcinoma is less costly and more effective than long term active surveillance.
Lin JF; Jonker PKC; Cunich M; Sidhu SB; Delbridge LW; Glover AR; Learoyd DL; Aniss A; Kruijff S; Sywak MS
Surgery; 2020 Jan; 167(1):110-116. PubMed ID: 31543327
[TBL] [Abstract][Full Text] [Related]
10. Insights and clinical questions about the active surveillance of low-risk papillary thyroid microcarcinomas [Review].
Ito Y; Oda H; Miyauchi A
Endocr J; 2016 Apr; 63(4):323-8. PubMed ID: 26632168
[TBL] [Abstract][Full Text] [Related]
11. Incidences of Unfavorable Events in the Management of Low-Risk Papillary Microcarcinoma of the Thyroid by Active Surveillance Versus Immediate Surgery.
Oda H; Miyauchi A; Ito Y; Yoshioka K; Nakayama A; Sasai H; Masuoka H; Yabuta T; Fukushima M; Higashiyama T; Kihara M; Kobayashi K; Miya A
Thyroid; 2016 Jan; 26(1):150-5. PubMed ID: 26426735
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the costs of active surveillance and immediate surgery in the management of low-risk papillary microcarcinoma of the thyroid.
Oda H; Miyauchi A; Ito Y; Sasai H; Masuoka H; Yabuta T; Fukushima M; Higashiyama T; Kihara M; Kobayashi K; Miya A
Endocr J; 2017 Jan; 64(1):59-64. PubMed ID: 27667647
[TBL] [Abstract][Full Text] [Related]
13. Indications and Strategy for Active Surveillance of Adult Low-Risk Papillary Thyroid Microcarcinoma: Consensus Statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma.
Sugitani I; Ito Y; Takeuchi D; Nakayama H; Masaki C; Shindo H; Teshima M; Horiguchi K; Yoshida Y; Kanai T; Hirokawa M; Hames KY; Tabei I; Miyauchi A
Thyroid; 2021 Feb; 31(2):183-192. PubMed ID: 33023426
[No Abstract] [Full Text] [Related]
14. Low-risk papillary microcarcinoma of the thyroid: A review of active surveillance trials.
Ito Y; Miyauchi A; Oda H
Eur J Surg Oncol; 2018 Mar; 44(3):307-315. PubMed ID: 28343733
[TBL] [Abstract][Full Text] [Related]
15. Marked Decrease Over Time in Conversion Surgery After Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma.
Sasaki T; Miyauchi A; Ito Y; Kudo T; Kanemura N; Sano T; Kawano S; Yamamoto M; Fujishima M; Masuoka H; Higashiyama T; Kihara M; Miya A
Thyroid; 2021 Feb; 31(2):217-223. PubMed ID: 32664805
[No Abstract] [Full Text] [Related]
16. Active Surveillance Versus Immediate Surgery: Questionnaire Survey on the Current Treatment Strategy for Adult Patients with Low-Risk Papillary Thyroid Microcarcinoma in Japan.
Sugitani I; Ito Y; Miyauchi A; Imai T; Suzuki S
Thyroid; 2019 Nov; 29(11):1563-1571. PubMed ID: 31441377
[No Abstract] [Full Text] [Related]
17. Papillary thyroid microcarcinoma: time to shift from surgery to active surveillance?
Leboulleux S; Tuttle RM; Pacini F; Schlumberger M
Lancet Diabetes Endocrinol; 2016 Nov; 4(11):933-942. PubMed ID: 27550849
[TBL] [Abstract][Full Text] [Related]
18. Mortality Risk of Nonoperative Papillary Thyroid Carcinoma: A Corollary for Active Surveillance.
Ho AS; Luu M; Zalt C; Morris LGT; Chen I; Melany M; Ali N; Patio C; Chen Y; Mallen St-Clair J; Braunstein GD; Sacks WL; Zumsteg ZS
Thyroid; 2019 Oct; 29(10):1409-1417. PubMed ID: 31407637
[No Abstract] [Full Text] [Related]
19. Active surveillance of low-risk papillary thyroid microcarcinoma.
Sugitani I
Best Pract Res Clin Endocrinol Metab; 2023 Jan; 37(1):101630. PubMed ID: 35256266
[TBL] [Abstract][Full Text] [Related]
20. Active surveillance as a management strategy for papillary thyroid microcarcinoma.
Zhang H; Zheng X; Liu J; Gao M; Qian B
Cancer Biol Med; 2020 Aug; 17(3):543-554. PubMed ID: 32944389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
